The Departments of Clinical Research and Pharmaceutical Sciences integrate, becoming the Department of Pharmaceutical & Clinical Sciences

Instagram Accounts Added for all Programs

All CPHS programs now have their own Instagram accounts. Please follow us and let your colleagues, students, family and friends know about the accounts.

@official campbellPA

@campbellpharmsciclinresearch

The Department of Pharmaceutical & Clinical Sciences was established on January 1, 2022 from the merger of the Department of Pharmaceutical Sciences and the Department of Clinical Research. Dr. Charles A. Carter was appointed as chair of the newly formed department on July 1 of the same year.

“The merger has taken advantage of the synergy between the four-degree offerings within the legacy departments as well as their critical contributions to the Doctor of Pharmacy program. This collaboration has grown over the last several years and includes benefits in teaching, scholarship, and service that has enhanced the student academic experience, student recruitment, internal collaboration, and outside collaboration with the discovery, development, and research industries,” Dean of the College of Pharmacy & Health Sciences Dr. Michael L. Adams commented.

The integration of the two departments was well-received by the legacy departments’ faculty and staff. Prior to the merger, the legacy departments shared some teaching responsibilities. According to Dr. Michael R. Jiroutek, associate professor of Pharmaceutical & Clinical Sciences and adjunct associate professor of Pharmacy Practice, who has been teaching statistics to students majoring in clinical research and pharmaceutical sciences since 2012, “finding commonalities, through deeper collaborations amongst the programs, just makes sense.”

Students are benefitting from a broader and greater number of experiential opportunities in the form of residencies, co-ops, and internships while earning their chosen degree. Further, the department has taken advantage of opportunities to collaborate with external healthcare and life science industries. These efforts will prepare current and future students for the dynamic roles and responsibilities they will encounter on the “drug development spectrum from drug discovery and manufacturing to clinical trials and testing in human beings. The combined strengths and experiences of the faculty members in each department is a great asset to preparing students for positions in these areas,” added Dr. Timothy Marks, assistant professor Pharmaceutical & Clinical Sciences.

Key external stakeholders are excited about the departmental merger and have extended support. The strategic direction of the department links directly with the vision of the industry. According to Carter, “The approach for discovery and development of novel treatment and therapies in the industry is far faster and more efficient than in the past. When you speak to employers and external stakeholders, this merger is consistent with their respective integration and collaboration across the basic and clinical sciences, the areas of manufacturing, and the demand for quality products in a regulated environment.”

The newly formed PCS team has already been granted funding from the Burroughs Wellcome Fund to support a novel program. The initiative, Academy for Emerging Scholars Exploring Clinical Research and Pharmaceutical Science Careers, is providing engaging activities for rural high school students to learn STEM skills and build awareness of STEM-related careers.

The overall progress of the department since the merger has been exciting. “The merger is providing synergistic benefits possible only through the collective efforts of the newly combined department,” shared Carter.

@campbelluni versityseo

@campbelluni versityIPE

@campbellpu blichealth

@campb ellnursing

@camp bellPharmD

@officialc ampbelldpt

Aseptic Compounding Lab Space Now In Use

The renovation of a lab, Maddox 316, to accommodate aseptic (sterile and unsterile) compounding equipment is complete and use of the space began in January. Megan Taylor (’21 PharmD/MSCR), a PGY2 critical care resident at UNC Rex Hospital in Raleigh, and Matt DeBrine (’15 PharmD/ MBA), a critical care pharmacist at UNC Rex Hospital in Raleigh, came back to campus to teach the first lab course in the space. Other alumni are also planning to share